More on BIOD

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.5 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BIOD Balance Sheet

Click line-items for a historical chart and %
Current:
Cash and cash equivalents 31.02M
Restricted cash
Marketable securities, available for sale
Taxes receivable
Other receivables
Prepaid and other assets 283K
Total current assets 31.33M
Property and equipment, net 0
Intellectual property, net 34K
Other assets
Total assets 31.36M
Current:
Accounts payable 467K
Clinical trial expenses 1K
Payroll and related 344K
Accounting and legal fees 441K
Severance
Other
Income taxes payable
Total current liabilities 2.77M
Common stock warrant liability 7K
Other long term liabilities
Total liabilities 3.4M
Commitments 0
Series A preferred stock, $.01 par value; 50,000,000 shares authorized; 0 and 1,813,944 outstanding 0
Common stock, $.01 par value; 100,000,000 shares authorized; 26,399,764 and 38,605,483 issued and outstanding 641K
Additional paid-in capital 287.79M
Accumulated other comprehensive income
Deficit accumulated during the development stage
Total stockholders' equity
Total liabilities and stockholders' equity 31.36M